Quick Overview.
5-Amino-1MQ (5-amino-1-methylquinolinium) is not actually a peptide; it is a small molecule. However, it is almost exclusively sold and discussed within the peptide and biohacking communities. It was developed by researchers at the University of Texas Medical Branch to specifically block an enzyme called NNMT (Nicotinamide N-methyltransferase).[1]
As you get older or gain weight, your fat cells start producing too much of this NNMT enzyme. Think of NNMT as a thief that steals the fuel (NAD+) your cells need to burn fat. 5-Amino-1MQ acts like a security guard that handcuffs the thief. With the thief gone, your cells get their fuel back, your metabolism speeds up, and your body starts burning fat efficiently again, even without changing your diet.[2]
- Primary Use Case: Fat loss, metabolic optimization, and NAD+ elevation.
- Mechanism: Highly selective inhibitor of the NNMT enzyme, which prevents the depletion of NAD+ via the salvage pathway, leading to increased basal metabolic rate and lipid oxidation.[1][2]
- Who it is for: Individuals looking for an oral fat-loss supplement that preserves muscle mass and does not cause the severe nausea associated with GLP-1 agonists.
- Who it is NOT for: Individuals with known severe methylation defects (e.g., severe MTHFR mutations), as inhibiting NNMT alters the body's methylation cycle.
Turn this protocol into your actual schedule.
Log every dose, every side-effect, and every PR on one timeline.
The Protocol & Usage Guide.
confidence_tier: well-established
Because 5-Amino-1MQ is a small molecule and not a peptide, it is highly bioavailable orally. You do not need to inject it. However, because of its relatively short half-life (4-7 hours), it is best split into multiple doses throughout the day to maintain steady blood levels.
Standard Dosing
| Experience Level | Dose | Frequency | Timing |
|---|---|---|---|
| Standard Protocol | 50 mg | 2-3 times daily | With meals |
| Aggressive Protocol | 100 mg | 2-3 times daily | With meals |
Cycle Length
- Standard Cycle: 4 to 8 weeks on, followed by 4 weeks off.
- Why Cycle? NNMT is a natural enzyme that your body uses to regulate methylation. Permanently turning it off for months or years could lead to an imbalance in your methyl donors (like SAMe).
- Discontinuation: Can be stopped abruptly. No taper required.
Nutritional Support & Recommended Supplements.
confidence_tier: well-established
| Supplement | Rationale | Recommended Dose |
|---|---|---|
| Methyl Donors (TMG or SAMe) | NNMT is a methyltransferase. Inhibiting it alters the body's methylation cycle. Supplementing with TMG (Trimethylglycine) ensures your body has the methyl groups it needs for other essential functions. | 500-1000mg TMG daily. |
| NAD+ Precursors (NMN/NR) | 5-Amino-1MQ stops the destruction of NAD+. Taking a precursor provides the raw materials to build more NAD+, creating a massive synergistic effect. | 500-1000mg NMN daily. |
Safety, Interactions & Side Effect Management.
confidence_tier: emerging
Side Effect Profile
| Side Effect | Severity | Frequency | Management |
|---|---|---|---|
| Insomnia / Restlessness | Mild | Occasional | Because it increases NAD+ and cellular energy, taking it too close to bedtime can cause sleep disturbances. Take the last dose by late afternoon. |
| Mild Headaches | Mild | Occasional | Can occur as the body adjusts to altered NAD+ levels. Ensure adequate hydration and electrolyte intake. |
Contraindications
- Absolute: Pregnant or breastfeeding women.
- Relative: Individuals with known methylation defects (e.g., severe MTHFR mutations) should proceed with caution and monitor symptoms.
Drug Interactions
- High-Dose Niacin (Vitamin B3): Niacin is metabolized by the NNMT enzyme. Inhibiting NNMT while taking high doses of Niacin could lead to an accumulation of Niacin and potential flushing or liver stress.
Common Stacks & Combinations.
confidence_tier: community
| Stack | Goal | Rationale |
|---|---|---|
| 5-Amino-1MQ + MOTS-c | The Ultimate Metabolic Stack | Highly Synergistic. 5-Amino-1MQ increases NAD+ and basal metabolic rate, while MOTS-c forces the mitochondria to burn the mobilized fat.[5] |
| 5-Amino-1MQ + Tirzepatide | Elite Recomposition | The GLP-1 handles the appetite, while 5-Amino-1MQ prevents the metabolic slowdown and muscle loss that usually accompanies rapid weight loss.[6] |
| 5-Amino-1MQ + NMN | Anti-Aging & Energy | NMN provides the building blocks for NAD+, and 5-Amino-1MQ prevents that NAD+ from being wasted by the NNMT enzyme.[7] |
Body Composition & Training Guide.
confidence_tier: community
- Muscle Preservation: In animal models, 5-Amino-1MQ actually increased the cross-sectional area of muscle fibers. It is excellent for use during a "cutting" phase to ensure you only lose fat, not hard-earned muscle.[1]
- Cardio: The increase in cellular NAD+ often translates to improved cardiovascular endurance.[8]
- Tracking Progress: Track body fat percentage (via DEXA or calipers) rather than just scale weight, as muscle preservation may keep the scale from dropping as rapidly as expected.
Storage, Handling & Accessibility.
confidence_tier: well-established
- Storage: Store oral capsules at room temperature in a cool, dry place away from direct sunlight.
- WADA Status: Not explicitly banned, though its metabolic effects could theoretically place it under scrutiny in the future.
Bloodwork Monitoring Guide.
confidence_tier: emerging
Before starting and after a cycle:
- Lipid Panel: To monitor improvements in triglycerides and cholesterol.
- Homocysteine: Because 5-Amino-1MQ affects the methylation cycle, monitoring homocysteine levels can ensure your methylation pathways remain balanced.
Comparison to Similar Compounds.
confidence_tier: well-established
| Feature | 5-Amino-1MQ | MOTS-c | Tesamorelin |
|---|---|---|---|
| Primary Target | NNMT Enzyme | Mitochondria (AMPK) | Pituitary (GH Release) |
| Mechanism | NAD+ salvage, Fat burning | Exercise mimetic | Visceral fat lipolysis |
| Administration | Oral | SubQ Injection | SubQ Injection |
| Muscle Effect | Preserves/Builds | Neutral | Preserves |
Deep Dive (For Advanced Researchers).
confidence_tier: well-established
Mechanism of Action
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small, membrane-permeable molecule discovered through high-throughput screening for selective inhibitors of the Nicotinamide N-methyltransferase (NNMT) enzyme.[1]
The mechanism revolves entirely around the salvage pathway of NAD+ (Nicotinamide Adenine Dinucleotide):
- The NNMT Problem: NNMT is an enzyme highly expressed in white adipose tissue and the liver. Its job is to take Nicotinamide (NAM) and attach a methyl group to it, creating 1-methylnicotinamide (1-MNA). This reaction consumes a methyl group from SAMe.[3]
- The NAD+ Drain: Nicotinamide (NAM) is supposed to be recycled back into NAD+ via the salvage pathway. When NNMT is overactive (as it is in obesity and aging), it permanently removes NAM from the salvage pathway, leading to a massive depletion of cellular NAD+.[4]
- The Solution: 5-Amino-1MQ is a highly selective, substrate site-targeting inhibitor of NNMT (IC50 = 1.2 μM). By blocking NNMT, it prevents the methylation of NAM.[1]
- The Result: NAM is forced back into the salvage pathway, leading to a dramatic increase in intracellular NAD+ levels. Elevated NAD+ activates Sirtuin-1 (SIRT1), which in turn increases cellular metabolism, mitochondrial biogenesis, and lipid oxidation (fat burning).[2]
Clinical Trial Summary
- Animal Models: In a landmark 2018 study, diet-induced obese mice treated with 5-Amino-1MQ showed a 30% reduction in body weight and a 40% reduction in fat mass over 11 days, without any change in food intake.[1]
- Muscle Hypertrophy: The same study noted that the treated mice actually had larger muscle fibers than the control group, indicating that the weight loss was entirely from adipose tissue.[1]
- Human Data: There are currently no published, peer-reviewed human clinical trials for 5-Amino-1MQ. All human data is anecdotal from the biohacking and functional medicine communities.
Frequently Asked Questions (FAQ).
confidence_tier: community
Q: Is 5-Amino-1MQ a peptide? A: No. Peptides are chains of amino acids. 5-Amino-1MQ is a small molecule (a quinoline derivative). It is grouped with peptides simply because it is sold by the same research chemical companies and used by the same community.
Q: Will it make me lose weight if I eat a terrible diet? A: In mice, it caused weight loss without a change in diet. In humans, anecdotal reports suggest it will prevent weight gain on a bad diet, but you still need a moderate caloric deficit to see significant, rapid fat loss.
Q: Can I take it with NMN or NAD+ supplements? A: Yes, this is highly recommended. NMN gives your body the raw materials to make NAD+, and 5-Amino-1MQ stops your fat cells from destroying that NAD+. They work perfectly together.
International Regulatory Status.
confidence_tier: well-established
| Agency | Status | Notes |
|---|---|---|
| US FDA | Unapproved | Available as a research chemical/supplement. Not FDA approved for therapeutic use. |
| WADA | Not Prohibited | Not explicitly banned. |
| UK MHRA | Unapproved | Not licensed for medical use. |
| EU EMA | Unapproved | Not licensed for medical use. |
Decision Tree.
confidence_tier: community
[Goal: Fat Loss without Injections?]
|
+-- Are you willing to take capsules 2-3 times a day?
|
+-- (Yes) -> Use 5-Amino-1MQ (50mg 2-3x daily).
| *Highly recommended to stack with NMN and TMG.*
|
+-- (No) -> Consider injectable options like AOD-9604 or Tirzepatide.Schema.org Data.
{
"@context": "https://schema.org",
"@type": "MedicalEntity",
"name": "5-Amino-1MQ",
"alternateName": ["5-amino-1-methylquinolinium", "NNMT Inhibitor"],
"description": "A small molecule inhibitor of the NNMT enzyme that prevents NAD+ depletion, leading to increased basal metabolic rate, fat burning, and muscle preservation.",
"legalStatus": {
"@type": "DrugLegalStatus",
"description": "Unapproved by FDA; available as a research chemical or supplement. Not prohibited by WADA."
}
}What we cited.
- Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152. doi:10.1016/j.bcp.2017.11.007
- Dimet-Wiley A, Wu Q, Wiley JT, et al. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Sci Rep. 2022;12(1):478. doi:10.1038/s41598-021-03670-5
- Roessler C, Kutzner CE, Kemnitz KR, et al. Nicotinamide N-methyltransferase: a new target for the treatment of metabolic disorders. Expert Opin Ther Targets. 2014;18(9):1043-1055. doi:10.1517/14728222.2014.936380
- Liu JR, Deng Y, et al. Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. Front Endocrinol (Lausanne). 2021;12:714856. doi:10.3389/fendo.2021.714856
- Sampson CM, Dimet AL, Neelakantan H, et al. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Sci Rep. 2021;11(1):5829. doi:10.1038/s41598-021-85051-6
- Kannt A, Rajagopal S, Kadnur SV, et al. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2018;8(1):3660. doi:10.1038/s41598-018-22081-7
- Ruf S, Rajagopal S, Kadnur SV, et al. Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2022;12(1):15514. doi:10.1038/s41598-022-19634-2
- Yang M, Wang B, Hou W, et al. NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024;12(7):e009133. doi:10.1136/jitc-2024-009133